UNTERSUCHUNGEN ZUM WIRKUNGSMECHANISMUS VON LOKALANAESTHETICA. VII. SYNTHESE ENANTIOMERER N-AMINOACYL-2.6-DIMETHYLANILINE, -BENZYLAMINE UND -2-PHENYLAETHYLAMINE = RECHERCHES SUR LE MECANISME D'ACTION DES ANESTHESIQUES LOCAUX. VII. SYNTHESE DES N-AMINOACYL-DIMETHYL-2,6 ANILINES, BENZYLAMINES ET PHENYL-2 ETHYLAMINES ENANTIOMERESSCHONENBERGER H; ENDRES W.1976; PHARMAZIE; DTSCH.; DA. 1976; VOL. 31; NO 1; PP. 30-32; BIBL. 2 REF.Article

UNTERSUCHUNGEN ZUM WIRKUNGSMECHANISMUS VON LOKALANAESTHETICA. VIII. UNTERSUCHUNGEN ZUR HERSTELLUNG ENANTIOMERER N-PHTHALYLAMINOCARBONSAEUREN. = RECHERCHES SUR LE MECANISME D'ACTION DES ANESTHESIQUES LOCAUX. VIII. RECHERCHES SUR L'OBTENTION DES ACIDES N-PHTALYLAMINOCARBOXYLIQUES ENANTIOMERESSCHONENBERGER H; ENDRES W.1976; PHARMAZIE; DTSCH.; DA. 1976; VOL. 31; NO 11; PP. 811-813; BIBL. 9 REF.Article

AZOMETHINE UND OXAZOLIDINE DES NORFENEFRINS. VERSUCHE ZUR ENTWICKLUNG VON VERBINDUNGEN MIT LANGANHALTENDER BLUTDRUCKSTEIGERNDER WIRKUNG = LES AZOMETHINES ET LES OXAZOLIDINES DE LA NORFENEFRINE. RECHERCHES SUR LE DEVELOPPEMENT DE COMPOSES ACCROISSANT LA PRESSION SANGUINE DE FACON PERSISTANTESCHONENBERGER H; PETTER A; KUHLING V et al.1975; ARCH. PHARM.; DTSCH.; DA. 1975; VOL. 308; NO 9; PP. 717-719; BIBL. 5 REF.Article

UEBER CYTOSTATICA. XXII. TUMORHEMMENDE N-(BIS-(2-CHLORAETHYL)-AMINOMETHYL)-URETHANE. = CYTOSTATIQUES. XXII. N-(BIS-(CHLORO-2 ETHYL)-AMINOMETHYL) URETHANES ANTITUMORAUXSCHONENBERGER H; SCHMIDT F; BINDL L et al.1975; Z. KREBSFORSCH. KLIN. ONKOL.; DTSCH.; DA. 1975; VOL. 84; NO 3; PP. 227-240; ABS. ANGL.; BIBL. 12 REF.Article

ZUR ANTIMYKOBAKTERIELLEN WIRKUNG VON N-ALKYLBENZYLAMINEN. = L'ACTIVITE ANTIMYCOBACTERIENNE DE N-ALKYLBENZYLAMINESRUCKDESCHEL G; STRANSKY D; SCHONENBERGER H et al.1977; PHARMAZIE; DTSCH.; DA. 1977; VOL. 32; NO 2; PP. 119-122Article

ANTIMYKOBAKTERIELLE N-ALKYLBENZYLAMINE: SYNTHESE UND TESTUNG VON 4-AMINOMETHYL-2-HYDROXY-BENZOESAEURE UND HOMOLOGEN = LES N-ALKYLBENZYLAMINES ANTIMYCOSIQUES. SYNTHESE ET EVALUATION DE L'ACIDE AMINOMETHYL-4 HYDROXY-2 BENZOIQUE ET HOMOLOGUESMEINDL W; ANGERER EV; RUCKDESCHEL G et al.1982; ARCH. PHARM. (WEINHEIM); ISSN 0365-6233; DEU; DA. 1982; VOL. 315; NO 11; PP. 941-946; ABS. ENG; BIBL. 5 REF.Article

Investigation of the conformational influences of the estrogenic activity of 1,2-bis(2,6-dichloro-4-hydroxyphenyl)-ethylenediamines of their platinum(II) complexes. II: Synthesis and studies on the estrogenic activity of cis- and trans[bis(2,6-dichloro-4-hydroxybenzylamine)]dihaloplatinum(II)-complexesGUST, R; SCHÖNENBERGER, H.Archiv der Pharmazie (Weinheim). 1994, Vol 327, Num 12, pp 763-769, issn 0365-6233Article

1,1,2-TRIPHENYLBUT-1-ENES: RELATIONSHIP BETWEEN STRUCTURES, ESTRADIOL RECEPTOR AFFINITY, AND MAMMARY TUMOR INHIBITING PROPERTIESSCHNEIDER MR; VON ANGRER E; SCHONENBERGER H et al.1982; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1982; VOL. 25; NO 9; PP. 1070-1077; BIBL. 28 REF.Article

Zur Antitumorwirkung o-substituierter [1,2-Bis(4-hydroxyphenyl)-ethylendiamin]dichloroplatin(II)-Komplexe und ihrer Methylether = A propos de l'activité antitumorale de complexes du dichloroplatine(II) avec la bis-(hydroxy-4 phényl)-1,2 éthylènediamine σ-substituée et leurs méthyléthers = About antitumor activity of σ-substituted [1,2-bis(4-hydroxyphényl)éthylenediamine] dichloroplatinum(II)-complexes and their methylethersKARL, J; SCHÖNENBERGER, H.Archiv der Pharmazie (Weinheim). 1988, Vol 321, Num 7, pp 405-410, issn 0365-6233Article

Breast cancer-inhibiting properties of leaving group derivatives of [1,2-bis(2,6-difluoro-3-hydroxyphenyl)ethylenediamine]platinum(II)GUST, R; SCHÖNENBERGER, H.European journal of medicinal chemistry. 1993, Vol 28, Num 2, pp 117-127, issn 0223-5234Article

Mammary tumor inhibiting [1,2-bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes. III: Relationship between structure and estrogenic activity of the diamine ligands, their sulfatoplatinum(II) and diiodoplatinum(II) complexesGUST, R; SCHÖNENBERGER, H.Archiv der Pharmazie (Weinheim). 1993, Vol 326, Num 7, pp 405-413, issn 0365-6233Article

Zur Antitumorwirkung von cis-Dichloro-bis-(α-aminosäureester) platin-Komplexen = Activité antitumorale des complexes cis-dichlorobis-(α-amino acide ester) du platine = On the antitumor activity of cis-dichlorobis-(α-amino acid ester) platinum complexesWAPPES, B; SCHÖNENBERGER, H.Archiv der Pharmazie (Weinheim). 1983, Vol 316, Num 10, pp 854-862, issn 0365-6233Article

Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexesSPRUSS, T; BERNHARDT, G; SCHICKANEDER, E et al.Journal of cancer research and clinical oncology. 1991, Vol 117, Num 5, pp 435-443, issn 0171-5216Article

EXPERIMENTELLE CHEMOTHERAPIE DES MAMMAKREBSES. EINE UEBERSICHT. = LA CHIMIOTHERAPIE EXPERIMENTALE DU CANCER DU SEIN. REVUESCHONENBERGER H; KRANZFELDER G; HOFFMANN E et al.1976; PHARMAZIE; DTSCH.; DA. 1976; VOL. 31; NO 9; PP. 590-597; BIBL. 82 REF.Article

SYNTHESE, IN VIVO- UND IN VITRO-UNTERSUCHUNGEN ZUR TUMORHEMMENDEN WIRKUNG VON CIS-DICHLORO-DIPEPTIDESTER-PLATIN(II)-KOMPLEXEN. = SYNTHESE, ETUDE IN VITRO ET IN VIVO DE L'EFFET ANTITUMORAL DES COMPLEXES DU CIS-DICHLORO-DIPEPTIDE ESTER- PLATINEBECK W; PURUCKER B; GIRNTH M et al.1976; Z. NATURFORSCH., B; DTSCH.; DA. 1976; VOL. 31; NO 6; PP. 832-845; ABS. ANGL.; BIBL. 2 P.Article

Reduction of the estrogenic side effects of the mammary tumor-inhibiting drug [1,2-bis(2,6-dichloro-4-hydroxyphenyl)-ethylenediamine]dichloroplatinum(II) by variation of ring substituentsGUST, R; KARL, J; FADERL, M et al.Archiv der Pharmazie (Weinheim). 1995, Vol 328, Num 5, pp 457-463, issn 0365-6233Article

Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. III, Combination experimentsLASKE, R; SCHÖNENBERGER, H; HOLLER, E et al.Archiv der Pharmazie (Weinheim). 1991, Vol 324, Num 3, pp 153-160, issn 0365-6233Article

Stereoisomeric Dichloro[1-(hydroxyphenyl)-2-phenyl-1,2-ethanediamine]platinum(II) complexes. I : SynthesisMÜLLER, R; GUST, R; KLEMENT, U et al.Chemische Berichte. 1991, Vol 124, Num 11, pp 2381-2389, issn 0009-2940Article

Antiestrogene N-(4-Hydroxyphenyl)-N-(1,1,1-trifluor-2-propyl)-4-hydroxybenzamide: Beeinflussung der Wirkung durch hydrophobe Reste in ortho-Position des Benzamidfragments = Antiœstrogène N-[hydroxy-4 phényl] N-[trifluoro-1,1,1 propyl-2] hydroxy-4 benzamide: influence sur l'activité, des groupes hydrophobes en position ortho sur le fragment benzamide = Antiestrogenic N-(4-hydroxyphenyl)-N-(1,1,1-trifluoro-2-propyl)-4-hydroxybenzamides: influence of hydrophobic groups substituted in the ortho-position of the benzamide-fragment on activityHARTMANN, R. W; VOM ORDE, H.-D; SCHONENBERGER, H et al.Archiv der Pharmazie (Weinheim). 1990, Vol 323, Num 2, pp 73-78, issn 0365-6233Article

A simple method of delayed processing of tumor tissue in a soft agar clonogenic assayKRISCHKE, W; HARTMANN, R; SCHNEIDER, M et al.Journal of cancer research and clinical oncology. 1988, Vol 114, Num 2, pp 170-176, issn 0171-5216Article

Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. II: Synthesis and estrogen receptor binding affinity of 4,4'-, 5,5'-, and 6,6'-disubstituted metahexestrolsHARTMANN, R. W; HEINDL, A; SCHÖNENBERGER, H et al.Journal of medicinal chemistry (Print). 1984, Vol 27, Num 5, pp 577-585, issn 0022-2623Article

Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanomaSPRUSS, T; BERNHARDT, G; SCHÖNENBERGER, H et al.Journal of cancer research and clinical oncology. 1995, Vol 121, Num 4, pp 193-202, issn 0171-5216Article

Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. I: The antibacterial effectLASKE, R; SCHÖNENBERGER, H; HOLLER, E et al.Archiv der Pharmazie (Weinheim). 1989, Vol 322, Num 12, pp 847-852, issn 0365-6233Article

Does [Meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graf; [Meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum (II) inhibits this processSCHLEMMER, R; SPRUSS, T; BERNHARDT, G et al.Archiv der Pharmazie (Weinheim). 2000, Vol 333, Num 2-3, pp 69-71, issn 0365-6233Article

(1,2-Diaryl-1,2-ethylenediamine)platinum(II) complexes with sulfato and 3-sulfopropionato leaving groups : investigations with different types of coordination in the solid state, in solution and reactions with nucleophilesMÜLLER, R; BEDNARSKI, P. J; SCHÖNENBERGER, H et al.Inorganica chimica acta. 1992, Vol 195, Num 1, pp 77-87, issn 0020-1693Article